Abstract
The objective of the study is to evaluate the nutritional status and determine its impact on clinical outcomes in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy (ICT)-based larynx preservation program without prophylactic feeding-tube placement. All patients with locally advanced (T3/4, N0-3, M0) hypopharyngeal squamous cell carcinoma, technically suitable for total pharyngolaryngectomy, treated by docetaxel, cisplatin and 5-fluorouracil (TPF)-ICT for larynx preservation at our institution between 2004 and 2013, were included in this retrospective study. Patients’ nutritional status was closely monitored. Enteral nutrition was used if and when a patient was unable to sustain per-oral nutrition and hydration. The impact of nutritional status on clinical outcomes was investigated in univariate and multivariate analysis. A total of 53 patients (42 men and 11 women, mean age = 58.6 ± 8.2 years) were included in this study. Six (11.3 %) patients had lost more than 10 % of their usual body weight before therapy. Compared with patients’ usual weight, the mean maximum patient weight loss during therapeutic management was 8.7 ± 4.5 kg. Enteral nutrition was required in 17 patients (32 %). We found no influence of the tested nutritional status-related factors on response to ICT, toxicity of ICT, overall, cause-specific and recurrence-free survival, and on post-therapeutic swallowing outcome. Maximum weight loss was significantly associated with a higher risk of enteral tube feeding during therapy (p = 0.03) and of complications (grade ≥3, p = 0.006) during RT. Without prophylactic feeding-tube placement, approximately one-third of the patients required enteral nutrition. There was no significant impact of nutritional status on oncologic or functional outcomes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Li X, Di B, Shang Y, Zhou Y, Cheng J, He Z (2009) Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas. Eur J Surg Oncol 35:1348–1353
Hirano S, Tateya I, Kitamura M et al (2010) Ten years single institutional experience of treatment for advanced hypopharyngeal cancer in Kyoto University. Acta Otolaryngol Suppl 563:56–61
Agopian B, Dassonville O, Chamorey E et al (2011) Total pharyngolaryngectomy in the 21st century: indications, oncologic and functional outcomes. Rev Laryngol Otol Rhinol (Bord) 132:209–214
Lefebvre JL, Ang KK (2009) Larynx preservation consensus panel. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary. Int J Radiat Oncol Biol Phys 73:1293–1303
Pointreau Y, Garaud P, Chapet S et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498–506
Jager-Wittenaar H, Dijkstra PU, Vissink A, Langendijk JA, van der Laan BF, Pruim J, Roodenburg JL (2011) Changes in nutritional status and dietary intake during and after head and neck cancer treatment. Head Neck 33:863–870
Chang MF, Wang HM, Kang CJ et al (2010) Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary—an experience in Taiwan. Radiat Oncol 5:91–98
Silander E, Nyman J, Bove M, Johansson L, Larsson S, Hammerlid E (2012) Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer: a randomized study. Head Neck 34:1–9
Ravasco P (2011) Nutritional support in head and neck cancer: how and why? Anticancer Drugs 22:639–646
Atasoy BM, Yonal O, Demirel B et al (2012) The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy. Eur Arch Otorhinolaryngol 269:275–282
O’Neil KH, Purdy M, Falk J, Gallo L (1999) The dysphagia outcome and severity scale. Dysphagia 14:139–145
Jager-Wittenaar H, Dijkstra PU, Vissink A, van der Laan BF, van Oort RP, Roodenburg JL (2011) Malnutrition and quality of life in patients treated for oral or oropharyngeal cancer. Head Neck 33:490–496
Bhayani MK, Hutcheson KA, Barringer DA, Roberts DB, Lewin JS, Lai SY (2013) Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence. Head Neck 35:1641–1646
Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2004) Cancer: disease and nutrition are key determinants of patients’ quality of life. Support Care Cancer 12:246–252
Williams GF, Teo MT, Sen M, Dyker KE, Coyle C, Prestwich RJ (2012) Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: a role for a prophylactic gastrostomy? Oral Oncol 48:434–440
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors report no conflicts of interest.
Rights and permissions
About this article
Cite this article
Bozec, A., Benezery, K., Chamorey, E. et al. Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program. Eur Arch Otorhinolaryngol 273, 2681–2687 (2016). https://doi.org/10.1007/s00405-015-3785-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-015-3785-4